TUBERCULOSIS RESEARCH UNIT

结核病研究室

• 批准号: 2296259
• 负责人: Jerrold J. Ellner
• 金额: $ 378.55万
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1994
• 资助国家: 美国
• 起止时间: 1994-09-30 至 1999-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2296259
• 关键词: TUBERCULOSIS; RESEARCH; UNIT

This contract is part of the NIAID's response to the global resurgence of Tuberculosis. This contract will have five components. Epidemiological studies will be performed to identify the factors which will ultimately improve our ability to design and implement tuberculosis prevention and treatment regimens. At the same time basic research efforts in immunology and microbiology will address the factors which define the "stages" of disease progression as well as the factors associated with disease prevention. The clinical research component will incorporate this knowledge base in the design and conduct of Phase 1/2 clinical trials. The fifth component will coordinate all these activities to assure the success of the multidisciplinary approach of this effort.

该合同是NIAID对全球复兴的回应的一部分 结核。 该合同将有五个组件。 流行病学 将进行研究以确定最终将最终的因素 提高我们设计和实施预防结核的能力， 治疗方案。 同时，免疫学基础研究工作 微生物学将解决定义的“阶段”的因素 疾病进展以及与疾病相关的因素 预防。 临床研究组件将结合起来 1/2期临床试验的设计和行为的知识基础。 这 第五部分将协调所有这些活动以确保成功 这项工作的多学科方法。